Literature DB >> 23934063

Cardiac spectrum, cytogenetic analysis and thyroid profile of 418 children with Down syndrome from South India: a cross-sectional study.

Dhanya Lakshmi Narayanan1, Dhanya Yesodharan, Mahesh Kappanayil, Shwetha Kuthiroly, M V Thampi, Zareena Hamza, Alka Anilkumar, K Mohandas Nair, K R Sundaram, R Krishna Kumar, Sheela Nampoothiri.   

Abstract

OBJECTIVE: To describe the spectrum of congenital heart disease in children with Down syndrome and their cytogenetic profile (and that of parents of those with translocation), and thyroid profile.
METHODS: A cross sectional study was conducted in 418 consecutive patients with Down syndrome attending the Department of Pediatric Genetics from a tertiary care centre in Kerala with a comprehensive Pediatric Cardiac Program, from November 2005 through April 2012. All children were offered cytogenetic analysis and were subjected to echocardiography. Parental karyotyping was offered for children with translocation type of Down syndrome. The thyroid profiles of all children were checked at the first visit and once every 6 mo during follow up.
RESULTS: Congenital heart disease was present in 256 (63.4 %) of 404 children with Down syndrome. Ventricular septal defect (72; 28.1 %) was the commonest, followed by atrio-ventricular septal defect (70; 27.3 %) and patent ductus arteriosus (43; 16.8 %). Surgical correction was accomplished in 104 (40.6 %) with excellent intermediate-term outcomes. Three hundred eighty seven of 418 children (92.6 %) underwent cytogenetic tests. The abnormalities included non-disjunction (340, 87.8 %), translocation (33, 8.5 %) and mosaicism (12, 3.1 %). Hypothyroidism was detected in 57 children (13.6 %).
CONCLUSIONS: The prevalence of congenital heart disease in children with Down syndrome in Kerala is the highest reported (63.4 %). Ventricular septal defect is the most common heart disease in the present study. The results highlight the changing attitudes of families towards the surgical correction of congenital heart disease in children with Down syndrome. Prevalence of hypothyroidism in Down syndrome in Kerala is 13.6 %.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23934063     DOI: 10.1007/s12098-013-1088-6

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  21 in total

1.  Cytogenetic studies of 1001 Down syndrome cases from Andhra Pradesh, India.

Authors:  A Jyothy; K S Kumar; G N Rao; V B Rao; M Swarna; B U Devi; M Sujatha; C K Kumari; P P Reddy
Journal:  Indian J Med Res       Date:  2000-04       Impact factor: 2.375

2.  Cytogenetic analysis of Down syndrome in Gujarat.

Authors:  Frenny Sheth; Subhada Rao; Manisha Desai; Jigna Vin; Jayesh Sheth
Journal:  Indian Pediatr       Date:  2007-10       Impact factor: 1.411

Review 3.  Cytogenetic studies in Down syndrome.

Authors:  I C Verma; S Mathew; R Elango; A Shukla
Journal:  Indian Pediatr       Date:  1991-09       Impact factor: 1.411

4.  Cytogenetic and epidemiological findings in Down syndrome, England and Wales 1989 to 1993. National Down Syndrome Cytogenetic Register and the Association of Clinical Cytogeneticists.

Authors:  D Mutton; E Alberman; E B Hook
Journal:  J Med Genet       Date:  1996-05       Impact factor: 6.318

5.  Study of Down syndrome in 238,942 consecutive births.

Authors:  C Stoll; Y Alembik; B Dott; M P Roth
Journal:  Ann Genet       Date:  1998

6.  Health supervision for children with Down syndrome.

Authors:  Marilyn J Bull
Journal:  Pediatrics       Date:  2011-07-25       Impact factor: 7.124

Review 7.  [Heart malformations in children with Down syndrome].

Authors:  Jesús de Rubens Figueroa; Blanca del Pozzo Magaña; José L Pablos Hach; Claudia Calderón Jiménez; Rocío Castrejón Urbina
Journal:  Rev Esp Cardiol       Date:  2003-09       Impact factor: 4.753

8.  Down syndrome: clinical profile from India.

Authors:  Maina P Kava; Milind S Tullu; Mamta N Muranjan; K M Girisha
Journal:  Arch Med Res       Date:  2004 Jan-Feb       Impact factor: 2.235

9.  Prevalence of congenital heart defects and persistent pulmonary hypertension of the neonate with Down syndrome.

Authors:  Michel Emile Weijerman; A Marceline van Furth; Maurike D van der Mooren; Miriam M van Weissenbruch; Lukas Rammeloo; Chantal J M Broers; Reinoud J B J Gemke
Journal:  Eur J Pediatr       Date:  2010-04-23       Impact factor: 3.183

10.  Ethnicity, sex, and the incidence of congenital heart defects: a report from the National Down Syndrome Project.

Authors:  Sallie B Freeman; Lora H Bean; Emily G Allen; Stuart W Tinker; Adam E Locke; Charlotte Druschel; Charlotte A Hobbs; Paul A Romitti; Marjorie H Royle; Claudine P Torfs; Kenneth J Dooley; Stephanie L Sherman
Journal:  Genet Med       Date:  2008-03       Impact factor: 8.822

View more
  5 in total

1.  Down Syndrome with Patent Ductus Venosus and Hepato-Biliary-Pancreatic Abnormalities.

Authors:  Hiroshi Yamaguchi; Kiyotaka Kosugiyama; Shohei Honda; Okada Tadao; Akinobu Taketomi; Seido Iwata
Journal:  Indian J Pediatr       Date:  2015-06-23       Impact factor: 1.967

2.  Congenital Heart Disease and Its Association in Children With Down Syndrome.

Authors:  Yasir Rehman; Haseen Dil Wazir; Ali Akbar; Abdul Moeed Khan; Ijaz Hussain; Amir Afridi; Huma Gul; Haleema Sadia
Journal:  Cureus       Date:  2022-09-14

3.  Congenital heart disease and Down syndrome: various aspects of a confirmed association.

Authors:  Sanaa Benhaourech; Abdenasser Drighil; Ayoub El Hammiri
Journal:  Cardiovasc J Afr       Date:  2016 Sep/Oct       Impact factor: 1.167

4.  Pattern of congenital heart disease among Egyptian children: a 3-year retrospective study.

Authors:  Marwa Moustapha Al-Fahham; Yasmin Abdelrazek Ali
Journal:  Egypt Heart J       Date:  2021-01-29

5.  The spectrum of congenital heart diseases in down syndrome. A retrospective study from Northwest Saudi Arabia.

Authors:  Mohamed M Morsy; Osama O Algrigri; Sherif S Salem; Mostafa M Abosedera; Ashraf R Abutaleb; Khaled M Al-Harbi; Ibrahim S Al-Mozainy; Abdulhameed A Alnajjar; Abdelhadi M Habeb; Hany M Abo-Haded
Journal:  Saudi Med J       Date:  2016-07       Impact factor: 1.484

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.